Advocacy intelligence hub — real-time data for patient organizations
Endari: FDA approved
To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.
Ammonul: FDA approved
Adjunctive therapy in the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Ammonul
Medicis Pharmaceutical Corp.
Browse all Acute encephalopathy with biphasic seizures and late reduced diffusion news →
View all Acute encephalopathy with biphasic seizures and late reduced diffusion specialists →